Copenhagen -based VitrigistA medtech startup on the back of technology that properly measures cardiorespiral fitness (CRF), has just shut down $ 1.7 million funds after the expansion of several European markets.
This round, mainly led by existing investors, is based on the previous rise in 2021 and 2024. Investors Denmark’s Export and Investment Fund (EIFO), Techstation | HardTech Innovation Hub, Investo Capital and Private Investor, Kursten Standvad, a former CEO of Denmark’s largest pension fund.
CEO Mickel ChristianSen Shared with EU-Startups: “We are incredibly proud of our endless beliefs from our existing investors as well as the new investors who came on the board. From potential customers, partners and investors – we have a lot of interest in the past one year as a company. We have created a product that we truly resonate over the time, where there is an extended focus on preventive health and healthy and prolonged living.
“We see it in our European markets and from the American market we are also very interested there, so the next time will be really exciting for us as an organization and this capital injection will help to intensify the journey we are doing right now.“
The ventricle is a spinout from the University of Alberg in Denmark and the company has already prepared a final product for commercialization by 2021.
Flagship devices, cisomophit, a CE-church medical device that uses a technology called seismocardiography to measure the speed of the chest wall due to the vibration of the heart.
With the seismophit system, a person’s cardiorespiece fitness (VO2 is the highest) can be estimated in less than 3 minutes without the use of exercise. Using it together with ventricle algorithm, the image of VO2 Max is provided to the user via the ventricle app.
Anders Throop-Jansen Said from Eiffo “We are very pleased to invest in the latest investment round of ventricle. We believe in the company since 2021 in the company of investors and VO2 Max measurements in the strong future for the company as the leader of the market. We are very impressed with their skills to open the team and the new market. We are hoping to continue working with the management team as our sales grow in the EU and the United StatesThe “
CEO ChristianSen Nordic startup scenes are watching the ventricle benefit from a more broad boom. He says that though Denmark is well recognized as an innovative technical launch factory, especially interest in HealthThech is increasing. He referred to the Novo Holdings to invest € 48 million in investment and Denmark’s export and investment fund (EIFO) on the Nordic HealthThek as an example of waking up in this region in Healthcape IX Fund.
The startup says they have several European market customers and recently signed distributors in Denmark, Netherlands, Sweden, Switzerland and the UK.
They are in the final discussion with several healthcare suppliers across Europe. Ventricize is also exploring entry into the US market. It will provide access to more than 55,000 health clubs and the world’s largest health care market.
[publish_date
